BioHealth Capital Region Women Making Waves in Venture Capital

Published on :

Improving access to venture capital for life science entrepreneurs and emerging biopharma companies in the BioHealth Capital Region (BHCR) is a top priority. However, elevating the region’s funding profile is not the only type of access undergoing a transformation in recent years.

5 Questions with Paul Nolde, Fund Manager/Managing Director, Riverflow Growth Fund

Published on :

Paul Nolde has close to two decades of experience in the banking, finance, and venture capital sectors, serving in multiple business development and management roles. As the Fund Manager and Managing Director of Riverflow Growth Fund, a seed-stage venture capital fund based in Richmond, VA, Paul is responsible for all aspects of fund management and investment-related processes.

Seeking Funding During a Pandemic: Panel Discusses Recent Trends in Life Science Capital

Published on :

COVID-19 has created significant challenges for the Venture Capital (VC) market and life science companies seeking funding during the pandemic. While the pandemic has undoubtedly added a new layer of risk to an inherently risky field, the fundamentals for what makes a company attractive to a VC have remained steady.

5 Questions with Ken Malone, Co-Founder, and Principal, Early Charm Ventures, LLC.

Published on :

Ken Malone is a co-founder of Early Charm Ventures, a venture studio founded in 2012 in Baltimore (Charm City) that converts science to business. Early Charm specializes in taking brilliant scientific discoveries made at universities and turning them into companies focused on growth. They don’t chase quick exits. They build companies that create sustainable value.

Raising Capital During a Pandemic: Strong Networks and Respected Advocates Remain Critical to Fundraising Efforts

Raising Capital During a Pandemic
Published on :

Raising Capital During a Pandemic: Strong Networks and Respected Advocates Remain Critical to Fundraising Efforts Talk to any experienced venture capital investor and they’ll tell you that personal, face-to-face interactions [….]